'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization
- PMID: 8844834
- DOI: 10.1093/protein/9.7.617
'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization
Abstract
'Knobs-into-holes' was originally proposed by Crick in 1952 as a model for the packing of amino acid side chains between adjacent alpha-helices. 'Knobs-into-holes' is demonstrated here as a novel and effective design strategy for engineering antibody heavy chain homodimers for heterodimerization. In this approach a 'knob' variant was first obtained by replacement of a small amino acid with a larger one in the CH3 domain of a CD4-IgG immunoadhesin: T366Y. The knob was designed to insert into a 'hole' in the CH3 domain of a humanized anti-CD3 antibody created by judicious replacement of a large residue with a smaller one: Y407T. The anti-CD3/CD4-IgG hybrid represents up to 92% of the protein A purified protein pool following co-expression of these two different heavy chains together with the anti-CD3 light chain. In contrast, only up to 57% of the anti-CD3/CD4-IgG hybrid is recovered following co-expression in which heavy chains contained wild-type CH3 domains. Thus knobs-into-holes engineering facilitates the construction of an antibody/immunoadehsin hybrid and likely other Fc-containing bifunctional therapeutics including bispecific immunoadhesins and bispecific antibodies.
Similar articles
-
Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library.J Mol Biol. 1997 Jul 4;270(1):26-35. doi: 10.1006/jmbi.1997.1116. J Mol Biol. 1997. PMID: 9231898
-
Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.Protein Eng Des Sel. 2017 Sep 1;30(9):649-656. doi: 10.1093/protein/gzx041. Protein Eng Des Sel. 2017. PMID: 28985438
-
A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies.Antib Ther. 2022 Aug 1;5(3):216-225. doi: 10.1093/abt/tbac019. eCollection 2022 Jul. Antib Ther. 2022. PMID: 36042698 Free PMC article.
-
Bispecific human IgG by design.J Immunol Methods. 2001 Feb 1;248(1-2):7-15. doi: 10.1016/s0022-1759(00)00339-2. J Immunol Methods. 2001. PMID: 11223065 Review.
-
Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development.MAbs. 2019 Nov-Dec;11(8):1341-1350. doi: 10.1080/19420862.2019.1664365. Epub 2019 Sep 26. MAbs. 2019. PMID: 31556789 Free PMC article. Review.
Cited by
-
Using protein geometry to optimize cytotoxicity and the cytokine window of a ROR1 specific T cell engager.Front Immunol. 2024 Feb 22;15:1323049. doi: 10.3389/fimmu.2024.1323049. eCollection 2024. Front Immunol. 2024. PMID: 38455046 Free PMC article.
-
An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies.Antibodies (Basel). 2024 Feb 8;13(1):14. doi: 10.3390/antib13010014. Antibodies (Basel). 2024. PMID: 38390875 Free PMC article.
-
Design and engineering of bispecific antibodies: insights and practical considerations.Front Bioeng Biotechnol. 2024 Jan 25;12:1352014. doi: 10.3389/fbioe.2024.1352014. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38333084 Free PMC article. Review.
-
A bibliometric and knowledge-map analysis of bispecific antibodies in cancer immunotherapy from 2000 to 2023.Heliyon. 2024 Jan 17;10(2):e23929. doi: 10.1016/j.heliyon.2023.e23929. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312701 Free PMC article.
-
Large scale controlled Fab exchange GMP process to prepare bispecific antibodies.Front Bioeng Biotechnol. 2024 Jan 12;11:1298890. doi: 10.3389/fbioe.2023.1298890. eCollection 2023. Front Bioeng Biotechnol. 2024. PMID: 38283167 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials